Although darunavir once daily, atazanavir once daily, and fosamprenavir twice daily, each with the appropriate ritonavir-boosting ... each in combination with tenofovir and emtricitabine.

TITAN is an ongoing, randomized, controlled, open-label, multinational, 96-week Phase III trial in treatment-experienced, LPV-naive patients. [10] Patients were HIV-1-infected adults with a plasma ...